Foghorn Therapeutics Inc. Common Stock (FHTX)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 106
- Market Cap
- $278M
About Foghorn Therapeutics Inc. Common Stock
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
SentiSense also tracks daily options readings for Foghorn Therapeutics Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Foghorn Therapeutics Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.